Literature DB >> 26094914

NKp30 isoforms in patients with chronic hepatitis C virus infection.

Stefania Mantovani1, Dalila Mele1, Barbara Oliviero1, Giorgio Barbarini2, Stefania Varchetta1, Mario U Mondelli1,3.   

Abstract

Natural killer (NK) cells play an important role in virus infection, their action being regulated by several activating and inhibitory receptors. The NKp30 activating receptor and its isoforms have recently emerged as important determinants of efficient NK cell responses. We determined the relative proportions of NKp30 isoforms in patients with chronic hepatitis C virus (HCV) infection and healthy donors (HD). NK cell function (degranulation and cytokine production) and correlations with clinical parameters were assessed following unsupervised hierarchical clustering of patients according to isoform expression. NKp30 receptor expression on NK cells and all isoforms were reduced in HCV-infected patients. Patients were clustered into two groups: the HCV-1 group had similar isoform expression to the HD group, whereas the HCV-2 group had lower expression. The latter showed a better functional activity, and a higher proportion of the activating a isoform and of the NKp30 isoform a/c ratio compared with the HCV-1 cluster. There was a positive correlation between the activating a isoform and liver stiffness and an inverse relationship between the immunosuppressive c isoform and the fibrosis 4 score, suggesting a potentially important role of NKp30 isoforms in influencing liver damage and ensuing fibrosis.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  interferon-γ; liver fibrosis; natural killer cells; unsupervised hierarchical clustering

Mesh:

Substances:

Year:  2015        PMID: 26094914      PMCID: PMC4582964          DOI: 10.1111/imm.12495

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  29 in total

1.  A new member of the Ig superfamily and a V-ATPase G subunit are among the predicted products of novel genes close to the TNF locus in the human MHC.

Authors:  M J Neville; R D Campbell
Journal:  J Immunol       Date:  1999-04-15       Impact factor: 5.422

2.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 3.  Evolutionary struggles between NK cells and viruses.

Authors:  Lewis L Lanier
Journal:  Nat Rev Immunol       Date:  2008-03-14       Impact factor: 53.106

4.  Increased natural cytotoxicity receptor expression and relevant IL-10 production in NK cells from chronically infected viremic HCV patients.

Authors:  Andrea De Maria; Manuela Fogli; Stefania Mazza; Monica Basso; Antonio Picciotto; Paola Costa; Sonia Congia; Maria Cristina Mingari; Lorenzo Moretta
Journal:  Eur J Immunol       Date:  2007-02       Impact factor: 5.532

5.  Cell culture and infection system for hepatitis C virus.

Authors:  Takanobu Kato; Tomoko Date; Asako Murayama; Kenichi Morikawa; Daisuke Akazawa; Takaji Wakita
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

6.  NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor.

Authors:  Massimo Vitale; Mariella Della Chiesa; Simona Carlomagno; Daniela Pende; Maurizio Aricò; Lorenzo Moretta; Alessandro Moretta
Journal:  Blood       Date:  2005-03-22       Impact factor: 22.113

7.  Activating NK cell receptor expression/function (NKp30, NKp46, DNAM-1) during chronic viraemic HCV infection is associated with the outcome of combined treatment.

Authors:  Federica Bozzano; Antonino Picciotto; Paola Costa; Francesco Marras; Valentina Fazio; Ivan Hirsch; Daniel Olive; Lorenzo Moretta; Andrea De Maria
Journal:  Eur J Immunol       Date:  2011-10       Impact factor: 5.532

8.  A human monoclonal antibody specific for the N terminus of the hepatitis C virus nucleocapsid protein.

Authors:  A Cerino; P Boender; N La Monica; C Rosa; W Habets; M U Mondelli
Journal:  J Immunol       Date:  1993-12-15       Impact factor: 5.422

9.  Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections.

Authors:  Barbara Oliviero; Stefania Varchetta; Enrica Paudice; Giuseppe Michelone; Marco Zaramella; Domenico Mavilio; Francesca De Filippi; Savino Bruno; Mario U Mondelli
Journal:  Gastroenterology       Date:  2009-05-24       Impact factor: 22.682

10.  Analysis of NKp30/NCR3 isoforms in untreated HIV-1-infected patients from the ANRS SEROCO cohort.

Authors:  Nicole Prada; Guillemette Antoni; Frédéric Commo; Sylvie Rusakiewicz; Michaela Semeraro; Faroudy Boufassa; Olivier Lambotte; Laurence Meyer; Marie-Lise Gougeon; Laurence Zitvogel
Journal:  Oncoimmunology       Date:  2013-03-01       Impact factor: 8.110

View more
  12 in total

1.  Enhanced activation of human NK cells by drug-exposed hepatocytes.

Authors:  Frank Fasbender; Martin Obholzer; Sarah Metzler; Regina Stöber; Jan G Hengstler; Carsten Watzl
Journal:  Arch Toxicol       Date:  2020-02-14       Impact factor: 5.153

Review 2.  Natural Killer Cells and Liver Fibrosis.

Authors:  Frank Fasbender; Agata Widera; Jan G Hengstler; Carsten Watzl
Journal:  Front Immunol       Date:  2016-01-29       Impact factor: 7.561

3.  NKp44 and NKp30 splice variant profiles in decidua and tumor tissues: a comparative viewpoint.

Authors:  Avishai Shemesh; Aleksandra Kugel; Naama Steiner; Michal Yezersky; Dan Tirosh; Avishay Edri; Omri Teltsh; Benyamin Rosental; Eyal Sheiner; Eitan Rubin; Kerry S Campbell; Angel Porgador
Journal:  Oncotarget       Date:  2016-10-25

Review 4.  Regulation of the Functions of Natural Cytotoxicity Receptors by Interactions with Diverse Ligands and Alterations in Splice Variant Expression.

Authors:  Tatiana Pazina; Avishai Shemesh; Michael Brusilovsky; Angel Porgador; Kerry S Campbell
Journal:  Front Immunol       Date:  2017-03-30       Impact factor: 7.561

5.  Expression of NKp46 Splice Variants in Nasal Lavage Following Respiratory Viral Infection: Domain 1-Negative Isoforms Predominate and Manifest Higher Activity.

Authors:  Yonat Shemer-Avni; Kiran Kundu; Avishai Shemesh; Michael Brusilovsky; Rami Yossef; Mesfin Meshesha; Semaria Solomon-Alemayehu; Shai Levin; Orly Gershoni-Yahalom; Kerry S Campbell; Angel Porgador
Journal:  Front Immunol       Date:  2017-02-15       Impact factor: 7.561

6.  Activated hepatic stellate cells impair NK cell anti-fibrosis capacity through a TGF-β-dependent emperipolesis in HBV cirrhotic patients.

Authors:  Jijing Shi; Juanjuan Zhao; Xin Zhang; Yongqian Cheng; Jinhua Hu; Yuanyuan Li; Xin Zhao; Qinghua Shang; Yanling Sun; Bo Tu; Lei Shi; Bin Gao; Fu-Sheng Wang; Zheng Zhang
Journal:  Sci Rep       Date:  2017-03-14       Impact factor: 4.379

Review 7.  Immunoregulatory Role of NK Cells in Tissue Inflammation and Regeneration.

Authors:  Annie Tosello-Trampont; Fionna A Surette; Sarah E Ewald; Young S Hahn
Journal:  Front Immunol       Date:  2017-03-20       Impact factor: 7.561

8.  Increased CD56(bright) NK cells in HIV-HCV co-infection and HCV mono-infection are associated with distinctive alterations of their phenotype.

Authors:  Suvercha Bhardwaj; Fareed Ahmad; Heiner Wedemeyer; Marcus Cornberg; Julian Schulze Zur Wiesch; Jan van Lunzen; Shiv K Sarin; Reinhold E Schmidt; Dirk Meyer-Olson
Journal:  Virol J       Date:  2016-04-18       Impact factor: 4.099

Review 9.  Ambiguous roles of innate lymphoid cells in chronic development of liver diseases.

Authors:  Yue Shen; Jing Li; Si-Qi Wang; Wei Jiang
Journal:  World J Gastroenterol       Date:  2018-05-14       Impact factor: 5.742

Review 10.  Engineering of chimeric natural killer cell receptors to develop precision adoptive immunotherapies for cancer.

Authors:  J Obajdin; D M Davies; J Maher
Journal:  Clin Exp Immunol       Date:  2020-07-25       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.